{
    "URL": "https://doi.org/10.1371/journal.pntd.0003101",
    "Published": "September 4, 2014",
    "Subject_Areas": [
        "Chikungunya virus",
        "Viral vaccines",
        "Recombinant vaccines",
        "Chikungunya infection",
        "Antibodies",
        "Recombinant proteins",
        "Spleen",
        "Vaccinia virus"
    ],
    "Authors": {
        "Petra van den Doel": [
            "Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands"
        ],
        "Asisa Volz": [
            "Institute for Infectious Diseases and Zoonoses, University of Munich LMU, Munich, Germany"
        ],
        "Jouke M. Roose": [
            "Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands"
        ],
        "Varsha D. Sewbalaksing": [
            "Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands"
        ],
        "Gorben P. Pijlman": [
            "Laboratory of Virology, Wageningen University, Wageningen, The Netherlands"
        ],
        "Ingeborg van Middelkoop": [
            "Laboratory of Virology, Wageningen University, Wageningen, The Netherlands"
        ],
        "Vincent Duiverman": [
            "Erasmus Medical Center Laboratory Animal Science Center (EDC), Rotterdam, The Netherlands"
        ],
        "Eva van de Wetering": [
            "Erasmus Medical Center Laboratory Animal Science Center (EDC), Rotterdam, The Netherlands"
        ],
        "Gerd Sutter": [
            "Institute for Infectious Diseases and Zoonoses, University of Munich LMU, Munich, Germany"
        ],
        "Albert D. M. E. Osterhaus": [
            "Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands",
            "Artemis One Health, Utrecht, The Netherlands"
        ],
        "Byron E. E. Martina": [
            "Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands",
            "Artemis One Health, Utrecht, The Netherlands"
        ]
    }
}